penpulimab
Showing 1 - 14 of 14
Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)
Recruiting
- Pheochromocytoma, Metastatic
- +2 more
- Penpulimab
-
Beijing, ChinaPeking Union Medical College Hospital
May 31, 2023
Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023
Penpulimab in Maintenance Therapy in Lymphoma
Not yet recruiting
- Lymphoma
- Penpulimab
- (no location specified)
Dec 25, 2022
Breast Cancer Trial in Chengdu (Disitamab Vedotin, Penpulimab)
Not yet recruiting
- Breast Cancer
- Disitamab Vedotin
- Penpulimab
-
Chengdu, Chengdu, Sichuan, China, ChinaWest China Hospital, Sichuan University
Feb 9, 2023
Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- Locally Advanced
- Short-course radiotherapy
- +3 more
- (no location specified)
Oct 8, 2022
NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Anlotinib Hydrochloride
- +2 more
- (no location specified)
Aug 2, 2022
Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Neoplasms
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022
Primary CNS Lymphoma Trial (Penpulimab)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- Penpulimab
- (no location specified)
Apr 20, 2022
Metastatic Colorectal Cancer Trial in Shanghai (Anlotinib, Penpulimab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Anlotinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)
Recruiting
- Thyroid Cancer
- Anlotinib hydrochloride
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 18, 2022
Gynecological Cancer Trial in Beijing, Chengdu (Penpulimab, Anlotinib)
Not yet recruiting
- Gynecological Cancer
- Penpulimab
- Anlotinib
-
Beijing, Beijing, China
- +1 more
Dec 28, 2021
Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)
Recruiting
- Hodgkin Disease Lymphoma
- Penpulimab
- Investigator's choice of Chemotherapy
-
Guangzhou, Guangdong, China
- +5 more
Feb 15, 2022